Clinical trials and cancer

Bob Riter is the retired Executive Director of the Cancer Resource Center. His articles about living with cancer appeared regularly in the Ithaca Journal and on OncoLink. He can be reached at bobriter@gmail.com.

A collection of Bob’s columns, When Your Life is Touched by Cancer: Practical Advice and Insights for Patients, Professionals, and Those Who Care, is available in bookstores nationwide and through online retailers such as Amazon and Barnes & Noble. All royalties from the sale of the book come to the Cancer Resource Center.

People diagnosed with cancer often wonder if they should participate in a clinical trial.

When someone asks for my opinion, I begin by saying that clinical trials are essential for the advancement of medicine. For example, one clinical trial found that women with early-stage breast cancer did just as well after a lumpectomy (followed by radiation), than did women who had a mastectomy. This finding greatly reduced the number of mastectomies that were being performed in this country and elsewhere.

That said, a clinical trial may or may not make the most sense for a specific individual at a specific point in time.

It’s helpful to have a general understanding of the different types of clinical trials.

A Phase 1 trial is a very small study to find out if a new treatment is safe. They aren’t testing the effectiveness of the treatment against a particular disease, just its safety in humans.

A Phase 2 trial is slightly larger and is used to determine if the new treatment seems to be effective in treating the disease under investigation.

A Phase 3 trial seeks to determine how the new treatment compares to existing treatments. Is it better, worse, or the same? The results of Phase 3 trials often change the standard of care.

Thus, clinical trials are good and are to be encouraged. Participating in a trial can also connect patients with clinicians and researchers who are experts in their particular type of cancer.

But it is important to remember that the “new” treatment does not always prove to be better than the standard treatment.

My advice for people considering a clinical trial is to talk with their oncologists as to which trials are available and the potential pros and cons of participating.

Here are some key points to consider:

  • How effective is the standard treatment likely to be in your situation? In some cases, the standard treatment is highly effective and easily tolerated. In other cases, the standard treatment doesn’t offer much hope. Knowing this information helps guide your decision-making.
  • Is it a Phase 1, Phase 2 or Phase 3 trial? Phase 1 and Phase 2 trials are more experimental and riskier than Phase 3 trials, but taking risks sometimes makes sense.
  • If considering a trial, I’d ask the physician to compare the new treatment with the standard treatment. What are the potential benefits and what are the potential side-effects for each? Making this head-to-head comparison provides useful context.
  • How convenient will it be for you to participate in the trial? While some trials are available locally, others require regular trips out of town. Some allow you to have blood tests and imaging (e.g., CT scans) performed locally. Others require that all tests be performed in the research hospital. Find out what’s required by the trial that you’re considering.


In sum, clinical trials are important, necessary, and worthwhile. Participating in a trial is altruistic because others with your disease will benefit. The benefit to you as an individual, however, depends on your specific situation. It’s a good conversation to have with your oncologist.

 

Click here for all of Bob’s columns

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on pinterest
Pinterest
Share on linkedin
LinkedIn
On Key

Related Posts

LIGHTS – CAMERA – ACTION!!

CRC wants to make you famous! We are looking for anyone who has been diagnosed with any kind of cancer for a portrait project “Why we are here!” There is

Collaboration with Hospicare

Hospicare & Palliative Care Services and the Cancer Resource Center  both share a common goal to be accessible to diverse populations throughout our community. CRC supports people living with and

New Zoom group!

Virtually Together is the name of our newest group. It will meet by Zoom and is open to everyone – cancer patients, survivors, loved ones, all genders, and those affected